NEW YORK (GenomeWeb News) – Pressure BioSciences today reported that its fourth quarter revenues increased 64 percent year over year as revenues derived from products and services more than doubled.

The South Easton, Mass.-based sample preparation products firm reported total revenues of $354,052 for the three months ended Dec. 31, 2013, compared to $216,032 for Q4 2012. Its revenues from products and services jumped to $300,628 from $122,285, while grant revenue declined to $53,424 from $93,747.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.